HomeMedicine
Medicine
Report: Medicare System Can Do More to Protect Beneficiaries
Alliance for Aging Research says utilization management practices such as step therapy and prior authorization could limit access to lower prescription drug prices and a cap on out-of-pocket costs at the pharmacy counterWASHINGTON, July 12, 2024 /PRNewswire/ -- While the Inflation Reduction Act (IRA)...
ImmuneAGE Bio launches to rejuvenate the immune system targeting bone marrow stem cells
SAN JUAN, Puerto Rico and LAUSANNE, Switzerland, July 12, 2024 /PRNewswire/ -- ImmuneAGE Bio raised $2M and has built the first drug discovery platform to rejuvenate the entire immune system at the source: the hematopoietic stem cell (HSCs) residing in the bone marrow. The...
Defend Your Skin Against Climate Change with QNET’s Revolutionary Visage+ Device USA – English APAC – English
HONG KONG, July 12, 2024 /PRNewswire/ -- QNET, a global leader in lifestyle and wellness-focused direct selling, proudly celebrates the success of its groundbreaking Physio Radiance Visage+ Facial Device. This state-of-the-art skincare solution leverages four advanced technologies to combat signs of aging and revitalise...
Emmaus Life Sciences Announces Outcome of FDA Inspection of Postmarketing Adverse Drug Experience Compliance Program
TORRANCE, Calif., July 12, 2024 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCPK: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today announced receiving the coveted "No Action Indicated" classification following a routine inspection by the United States Food and...
FDA Grants Fast Track Designation to 9MW2821 for the Treatment of Patients with Locally Advanced or Metastatic Nectin-4 Positive TNBC
SHANGHAI, July 12, 2024 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announces that its self-developed novel Nectin-4-targeting ADC (R&D Code: 9MW2821) has been granted Fast Track Designation (FTD) by the U.S. Food and Drug Administration (FDA) for the treatment...
PPG Biosensors Market to be dominated by Smartwatches Segment to reach USD 1001.73 Mn by 2030- Says Stellar Market Research
PUNE, India, July 12, 2024 /PRNewswire/ -- Stellar Market Research, a leading Healthcare business research firm has published a report on the "PPG Biosensors Market". The market size for the PPG Biosensors Market was USD 470.49 Mn in 2023 and is expected to grow...